首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Differential influence of increased polyol pathway on protein kinase C expressions between endoneurial and epineurial tissues in diabetic mice.
【24h】

Differential influence of increased polyol pathway on protein kinase C expressions between endoneurial and epineurial tissues in diabetic mice.

机译:增加的多元醇途径对糖尿病小鼠神经内膜和神经外膜组织之间蛋白激酶C表达的不同影响。

获取原文
获取原文并翻译 | 示例
           

摘要

To explore the relationship between polyol pathway and protein kinase C (PKC), we examined PKC activities and expressions of PKC isoforms separately in endoneurial and vessel-rich epineurial tissues in diabetic mice transgenic for human aldose reductase (Tg). Tg and littermate control mice (Lm) were made diabetic by streptozotocin at 8 weeks of age and treated orally with aldose reductase inhibitor (ARI) (fidarestat 3-5 mg/kg/day) or placebo for 12 weeks. At the end, compared with non-diabetic state, sorbitol contents were increased 6.4-fold in endoneurium and 5.1-fold in epineurium in diabetic Tg, whereas the increase was detected only in endoneurium in diabetic Lm. Endoneurial PKC activity was significantly reduced in diabetic Tg. By contrast, epineurial PKC activity was increased in both diabetic Lm and diabetic Tg and there was no significant difference between the two groups. These changes were all corrected by ARI treatment. Consistent with the changes of PKC activities, diabetic Tg showed decreased expression of PKCalpha in endoneurium, whereas there was an increased expression of PKCbetaII in epineurium in both diabetic Tg and diabetic Lm. These findings suggest the presence of dichotomous metabolic pathway between neural and vascular tissues in the polyol-PKC-related pathogenesis of diabetic neuropathy.
机译:为了探索多元醇途径与蛋白激酶C(PKC)之间的关系,我们分别检查了转染人醛糖还原酶(Tg)的糖尿病小鼠的神经内膜和富含血管的肾小管组织中PKC活性和PKC亚型的表达。用链脲佐菌素使8周龄的Tg和同窝出生的对照小鼠(Lm)患上糖尿病,并用醛糖还原酶抑制剂(ARI)(fidarestat 3-5 mg / kg / day)或安慰剂口服治疗12周。最后,与非糖尿病状态相比,糖尿病Tg中山梨糖醇含量在神经内膜中增加了6.4倍,在神经外膜中增加了5.1倍,而在糖尿病Lm中仅在神经内膜中发现了。糖尿病性Tg患者的神经内膜PKC活性明显降低。相比之下,糖尿病Lm和糖尿病Tg的肾小球PKC活性均增加,两组之间无显着差异。这些变化均通过ARI治疗得到纠正。与PKC活性的变化一致,糖尿病Tg显示神经内膜中PKCα的表达减少,而糖尿病Tg和糖尿病Lm中神经外膜中PKCbetaII的表达增加。这些发现表明在糖尿病性神经病的多元醇-PKC相关发病机理中,神经和血管组织之间存在二分代谢途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号